Challenges in REMS compliance

Am J Health Syst Pharm. 2021 Jun 7;78(12):1036-1037. doi: 10.1093/ajhp/zxab075.
No abstract available

Keywords: FDA; REMS; adverse drug effects; hospital practice; medication safety.

Publication types

  • Letter

MeSH terms

  • Humans
  • Risk Assessment
  • Risk Management*
  • United States
  • United States Food and Drug Administration